Results 21 to 30 of about 265,338 (259)

Gastric volvulus associated with shrinkage of a gastrointestinal stromal tumor by neoadjuvant imatinib: a case report

Journal of Medical Case Reports, 2023
Background During neoadjuvant chemotherapy for giant gastrointestinal stromal tumors, changes in gastrointestinal stromal tumor size are rarely associated with events such as perforation and bleeding that require emergency surgery.
Yoichi Sugiyama, Toshiaki Komo, Tatsuya Tazaki, Mohei Kohyama, Shinya Takahashi, Masaru Sasaki   +5 more
doaj   +1 more source

Duodenal Gastrointestinal Stromal Tumor

Journal of Clinical and Biomedical Sciences, 2019
Gastrointestinal stromal tumors (GIST) are nonepithelial tumors arising from the interstitial cells of Cajal. They express KIT protein-CD117 on immunohistochemistry.
Divya Teja Patil, Anil Kumar Sakalecha, Parameshwar Keerthi B.H, Yashas Ullas L   +3 more
doaj   +1 more source

Gastrointestinal stromal tumor metastasis to the ovary: A case report

SAGE Open Medical Case Reports, 2021
Gastrointestinal stromal tumors are common mesenchymal tumors of the gastrointestinal tract. The major site of metastasis for gastrointestinal stromal tumors is the liver or peritoneum, while metastasis to the ovary is exceptionally rare.
Takahisa Yamaguchi, Jun Kinoshita, Hiroto Saito, Mari Shimada, Shiro Terai, Hideki Moriyama, Koichi Okamoto, Keishi Nakamura, Hidehiro Tajima, Itasu Ninomiya, Yasutsugu Mizuno, Satoko Nakada, Sachio Fushida   +12 more
doaj   +1 more source

Rare Ovary Sclerosis Stromal Tumor: Case Report [PDF]

Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2020
Introduction: Sclerosing stromal tumor (SST) is a rare tumor of sex cord stromal tumor. Regarding to specific clinical, historical and hormonal feature, it has been differentiated from sex cord stromal tumor.
Setareh Akhavan, Mitra Modares Gilani, Sedigheh Ghasemian Dizajmehr, Farzaneh Rashidi Fakari, Elham Saffarieh, Masoomeh Safaei   +5 more
doaj   +1 more source

Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies

Frontiers in Cell and Developmental Biology, 2023
Introduction: The glycoengineered type II anti-CD20 monoclonal antibody obinutuzumab has been licensed for treatment in follicular non-Hodgkin lymphoma and B-CLL following clinical trials demonstrating superior outcomes to standard of care treatment ...
Ester Fagnano, Swati Pendharkar, Madyson Colton, Philip N. Jones, Marta Crespi Sallan, Tetyana Klymenko, Andrejs Braun, Christian Klein, Jamie Honeychurch, Eleanor J. Cheadle, Timothy M. Illidge   +10 more
doaj   +1 more source

Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model

Frontiers in Immunology, 2022
The tumor immune microenvironment significantly affects tumor progression, metastasis, and clinical therapy. Its basic cell components include tumor-associated endothelial cells, fibroblasts, and macrophages, all of which constitute the tumor stroma and ...
Changcan Li, Bao Jin, Hang Sun, Yunchao Wang, Haitao Zhao, Xinting Sang, Huayu Yang, Yilei Mao   +7 more
doaj   +1 more source

Emerging data supporting stromal cell therapeutic potential in cancer: reprogramming stromal cells of the tumor microenvironment for anti-cancer effects

Cancer Biology & Medicine, 2020
After more than a decade of controversy on the role of stromal cells in the tumor microenvironment, the emerging data shed light on pro-tumorigenic and potential anti-cancer factors, as well as on the roots of the discrepancies.
Armel H. Nwabo Kamdje, Paul F. Seke Etet, Richard Tagne Simo, Lorella Vecchio, Kiven Erique Lukong, Mauro Krampera   +5 more
doaj   +1 more source

Stromal CD10 expression in invasive breast carcinoma [PDF]

Zanco Journal of Medical Sciences, 2018
Background and Objective: This study aimed to assess the immunohistochemical expression of stromal CD10 in invasive breast carcinoma and determine its relationship with some clinicopathological parameters.
Haval D. Ali, Jalal A. Jalal, Ava T. Ismail, Wahda MT. Alnuaimy   +3 more
doaj   +1 more source

Rectal stromal tumor with an exceptional liver and bone metastatic locations

The Pan African Medical Journal, 2019
Gastrointestinal stromal tumours (GIST) are rare mesenchymal tumours which represent 1% to 3% of gastrointestinal neoplasm. Rectal location of GIST is extremely rare reaching 5% of GIST and only 0.1% of rectal tumours.
Dougaz Mohamed Wejih, Gouta Esma Leila, Chaouch Mohamed Ali, Nouira Ramzi, Bouasker Ibtissem, Dziri Chadli   +5 more
doaj   +1 more source

Integrating Tumor Stroma Biomarkers With Clinical Indicators for Colon Cancer Survival Stratification

Frontiers in Medicine, 2020
The tumor stroma plays an important role in tumor progression and chemotherapeutic resistance; however, its role in colon cancer (CC) survival prognosis remains to be investigated.
Yong Chen, Wenlong Wang, Bo Jiang, Lei Yao, Fada Xia, Xinying Li   +5 more
doaj   +1 more source